{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:25:29Z","timestamp":1790576729724,"version":"4.1.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05611-z","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T03:37:06Z","timestamp":1766806626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Deciphering the PGC-1\u03b1-TFAM Axis in Parkinson\u2019s Disease (PD) \u2014 A Mechanism Approach Targeting Therapeutics for PD"],"prefix":"10.1007","volume":"63","author":[{"given":"Mahalaxmi","family":"Iyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibbanti HariKrishna","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harysh Winster Suresh","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Lakhanpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayalakshmi","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Palanivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salmanul","family":"Faris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushboo","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balachandar","family":"Vellingiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"5611_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122610","author":"HWS Babu","year":"2024","unstructured":"Babu HWS, Kumar SM, Kaur H et al (2024) Midbrain organoids for Parkinson\u2019s disease (PD) - a powerful tool to understand the disease pathogenesis. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2024.122610","journal-title":"Life Sci"},{"key":"5611_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173815","volume":"894","author":"M Iyer","year":"2021","unstructured":"Iyer M, Subramaniam MD, Venkatesan D et al (2021) Role of RhoA-ROCK signaling in Parkinson\u2019s disease. Eur J Pharmacol 894:173815. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173815","journal-title":"Eur J Pharmacol"},{"key":"5611_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2022.134625","author":"B Vellingiri","year":"2022","unstructured":"Vellingiri B, Suriyanarayanan A, Selvaraj P et al (2022) Role of heavy metals (copper (Cu), arsenic (As), cadmium (Cd), iron (Fe) and lithium (Li)) induced neurotoxicity. Chemosphere. https:\/\/doi.org\/10.1016\/j.chemosphere.2022.134625","journal-title":"Chemosphere"},{"key":"5611_CR4","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979\u2013980. https:\/\/doi.org\/10.1126\/science.6823561","journal-title":"Science"},{"key":"5611_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pneurobio.2018.09.003","volume":"177","author":"A Gr\u00fcnewald","year":"2019","unstructured":"Gr\u00fcnewald A, Kumar KR, Sue CM (2019) New insights into the complex role of mitochondria in Parkinson\u2019s disease. Prog Neurobiol 177:73\u201393. https:\/\/doi.org\/10.1016\/j.pneurobio.2018.09.003","journal-title":"Prog Neurobiol"},{"key":"5611_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10863-009-9250-6","volume":"41","author":"A Navarro","year":"2009","unstructured":"Navarro A, Boveris A (2009) Brain mitochondrial dysfunction and oxidative damage in Parkinson\u2019s disease. J Bioenerg Biomembr 41:517\u2013521","journal-title":"J Bioenerg Biomembr"},{"key":"5611_CR7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","volume":"92","author":"P Puigserver","year":"1998","unstructured":"Puigserver P, Wu Z, Park CW et al (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829\u2013839","journal-title":"Cell"},{"key":"5611_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1172\/JCI10268","volume":"106","author":"JJ Lehman","year":"2000","unstructured":"Lehman JJ, Barger PM, Kovacs A et al (2000) Peroxisome proliferator\u2013activated receptor \u03b3 coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 106:847\u2013856","journal-title":"J Clin Invest"},{"key":"5611_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01756-w","volume":"9","author":"L Qian","year":"2024","unstructured":"Qian L, Zhu Y, Deng C et al (2024) Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases. Signal Transduct Target Ther 9:50. https:\/\/doi.org\/10.1038\/s41392-024-01756-w","journal-title":"Signal Transduct Target Ther"},{"key":"5611_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.1071163","volume":"296","author":"H Wu","year":"2002","unstructured":"Wu H, Kanatous SB, Thurmond FA et al (2002) Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296:349\u2013352","journal-title":"Science"},{"key":"5611_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","volume":"98","author":"Z Wu","year":"1999","unstructured":"Wu Z, Puigserver P, Andersson U et al (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115\u2013124","journal-title":"Cell"},{"key":"5611_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030101","volume":"3","author":"TC Leone","year":"2005","unstructured":"Leone TC, Lehman JJ, Finck BN et al (2005) PGC-1\u03b1 deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 3:e101","journal-title":"PLoS Biol"},{"key":"5611_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","volume":"119","author":"J Lin","year":"2004","unstructured":"Lin J, Wu P-H, Tarr PT et al (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1\u03b1 null mice. Cell 119:121\u2013135","journal-title":"Cell"},{"key":"5611_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","volume":"127","author":"J St-Pierre","year":"2006","unstructured":"St-Pierre J, Drori S, Uldry M et al (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127:397\u2013408","journal-title":"Cell"},{"key":"5611_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fnins.2020.00097","volume":"14","author":"X Yang","year":"2020","unstructured":"Yang X, Xu S, Qian Y et al (2020) Hypermethylation of the gene coding for PGC-1\u03b1 in peripheral blood leukocytes of patients with Parkinson\u2019s disease. Front Neurosci 14:97","journal-title":"Front Neurosci"},{"key":"5611_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001059","volume":"2","author":"B Zheng","year":"2010","unstructured":"Zheng B, Liao Z, Locascio JJ et al (2010) PGC-1\u03b1, a potential therapeutic target for early intervention in Parkinson\u2019s disease. Sci Transl Med 2:52ra73. https:\/\/doi.org\/10.1126\/scitranslmed.3001059","journal-title":"Sci Transl Med"},{"key":"5611_CR17","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/1873-3468.12989","volume":"592","author":"I Kang","year":"2018","unstructured":"Kang I, Chu CT, Kaufman BA (2018) The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms. FEBS Lett 592:793\u2013811. https:\/\/doi.org\/10.1002\/1873-3468.12989","journal-title":"FEBS Lett"},{"key":"5611_CR18","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1038\/ncomms4077","volume":"5","author":"HB Ngo","year":"2014","unstructured":"Ngo HB, Lovely GA, Phillips R, Chan DC (2014) Distinct structural features of TFAM drive mitochondrial DNA packaging versus transcriptional activation. Nat Commun 5:3077. https:\/\/doi.org\/10.1038\/ncomms4077","journal-title":"Nat Commun"},{"key":"5611_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1101\/gad.1138104","volume":"18","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Castellani LW, Sinal CJ et al (2004) Peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 (PGC-1\u03b1) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev 18:157\u2013169","journal-title":"Genes Dev"},{"key":"5611_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1210\/er.2002-0012","volume":"24","author":"P Puigserver","year":"2003","unstructured":"Puigserver P, Spiegelman BM (2003) Peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 (PGC-1\u03b1): transcriptional coactivator and metabolic regulator. Endocr Rev 24:78\u201390","journal-title":"Endocr Rev"},{"key":"5611_CR21","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1074\/jbc.C100631200","volume":"277","author":"J Lin","year":"2002","unstructured":"Lin J, Puigserver P, Donovan J et al (2002) Peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b2 (PGC-1\u03b2), a novel PGC-1-related transcription coactivator associated with host cell factor *. J Biol Chem 277:1645\u20131648. https:\/\/doi.org\/10.1074\/jbc.C100631200","journal-title":"J Biol Chem"},{"key":"5611_CR22","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S1097-2765(03)00391-5","volume":"12","author":"AE Wallberg","year":"2003","unstructured":"Wallberg AE, Yamamura S, Malik S et al (2003) Coordination of p300-mediated chromatin remodeling and TRAP\/mediator function through coactivator PGC-1\u03b1. Mol Cell 12:1137\u20131149. https:\/\/doi.org\/10.1016\/S1097-2765(03)00391-5","journal-title":"Mol Cell"},{"key":"5611_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0092-8674(91)90185-2","volume":"67","author":"H Li","year":"1991","unstructured":"Li H, Bingham PM (1991) Arginine\/serine-rich domains of the su(wa) and tra RNA processing regulators target proteins to a subnuclear compartment implicated in splicing. Cell 67:335\u2013342. https:\/\/doi.org\/10.1016\/0092-8674(91)90185-2","journal-title":"Cell"},{"key":"5611_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1097-2765(00)00031-9","volume":"6","author":"M Monsalve","year":"2000","unstructured":"Monsalve M, Wu Z, Adelmant G et al (2000) Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol Cell 6:307\u2013316. https:\/\/doi.org\/10.1016\/S1097-2765(00)00031-9","journal-title":"Mol Cell"},{"key":"5611_CR25","doi-asserted-by":"publisher","first-page":"15169","DOI":"10.1074\/jbc.M115.705822","volume":"291","author":"V Mart\u00ednez-Redondo","year":"2016","unstructured":"Mart\u00ednez-Redondo V, Jannig PR, Correia JC et al (2016) Peroxisome proliferator-activated receptor \u03b3 coactivator-1 \u03b1 isoforms selectively regulate multiple splicing events on target genes. J Biol Chem 291:15169\u201315184","journal-title":"J Biol Chem"},{"key":"5611_CR26","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.eplepsyres.2014.04.014","volume":"108","author":"V Villanueva","year":"2014","unstructured":"Villanueva V, Serratosa JM, Guillam\u00f3n E et al (2014) Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: results of the 1-year ESLIBASE retrospective study. Epilepsy Res 108:1243\u20131252. https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.04.014","journal-title":"Epilepsy Res"},{"key":"5611_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003614","volume":"3","author":"I Irrcher","year":"2008","unstructured":"Irrcher I, Ljubicic V, Kirwan AF, Hood DA (2008) AMP-activated protein kinase-regulated activation of the PGC-1\u03b1 promoter in skeletal muscle cells. PLoS One 3:e3614","journal-title":"PLoS One"},{"key":"5611_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00424-010-0834-0","volume":"460","author":"J Olesen","year":"2010","unstructured":"Olesen J, Kiilerich K, Pilegaard H (2010) PGC-1\u03b1-mediated adaptations in skeletal muscle. Pflugers Arch Eur J Physiol 460:153\u2013162","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"5611_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00435","volume":"10","author":"AP Gureev","year":"2019","unstructured":"Gureev AP, Shaforostova EA, Popov VN (2019) Regulation of mitochondrial biogenesis as a way for active longevity: interaction between the Nrf2 and PGC-1\u03b1 signaling pathways. Front Genet 10:435. https:\/\/doi.org\/10.3389\/fgene.2019.00435","journal-title":"Front Genet"},{"key":"5611_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12051075","author":"O Abu Shelbayeh","year":"2023","unstructured":"Abu Shelbayeh O, Arroum T, Morris S, Busch KB (2023) PGC-1\u03b1 is a master regulator of mitochondrial lifecycle and ROS stress response. Antioxidants. https:\/\/doi.org\/10.3390\/antiox12051075","journal-title":"Antioxidants"},{"key":"5611_CR31","doi-asserted-by":"publisher","first-page":"884S","DOI":"10.3945\/ajcn.110.001917","volume":"93","author":"PJ Fernandez-Marcos","year":"2011","unstructured":"Fernandez-Marcos PJ, Auwerx J (2011) Regulation of PGC-1\u03b1, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr 93:884S-890S. https:\/\/doi.org\/10.3945\/ajcn.110.001917","journal-title":"Am J Clin Nutr"},{"key":"5611_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/biom10020347","author":"M Fontecha-Barriuso","year":"2020","unstructured":"Fontecha-Barriuso M, Martin-Sanchez D, Martinez-Moreno JM et al (2020) The role of PGC-1\u03b1 and mitochondrial biogenesis in kidney diseases. Biomolecules. https:\/\/doi.org\/10.3390\/biom10020347","journal-title":"Biomolecules"},{"key":"5611_CR33","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1139\/apnm-2020-0005","volume":"45","author":"JF Halling","year":"2020","unstructured":"Halling JF, Pilegaard H (2020) PGC-1\u03b1-mediated regulation of mitochondrial function and physiological implications. Appl Physiol Nutr Metab 45:927\u2013936. https:\/\/doi.org\/10.1139\/apnm-2020-0005","journal-title":"Appl Physiol Nutr Metab"},{"key":"5611_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.nut.2015.08.017","volume":"32","author":"GT Diaz-Gerevini","year":"2016","unstructured":"Diaz-Gerevini GT, Repossi G, Dain A et al (2016) Beneficial action of resveratrol: how and why? Nutrition 32:174\u2013178. https:\/\/doi.org\/10.1016\/j.nut.2015.08.017","journal-title":"Nutrition"},{"key":"5611_CR35","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.metabol.2015.07.010","volume":"64","author":"RDR Hamidie","year":"2015","unstructured":"Hamidie RDR, Yamada T, Ishizawa R et al (2015) Curcumin treatment enhances the effect of exercise on mitochondrial biogenesis in skeletal muscle by increasing cAMP levels. Metabolism 64:1334\u20131347","journal-title":"Metabolism"},{"key":"5611_CR36","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1002\/art.39182","volume":"67","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhao X, Lotz M et al (2015) Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator\u2013activated receptor \u03b3 coactivator 1\u03b1. Arthritis Rheumatol 67:2141\u20132153","journal-title":"Arthritis Rheumatol"},{"key":"5611_CR37","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1139\/o06-064","volume":"84","author":"JR Blesa","year":"2006","unstructured":"Blesa JR, Hernandez-Yago J (2006) Distinct functional contributions of 2 GABP\u2013NRF-2 recognition sites within the context of the human TOMM70 promoter. Biochem Cell Biol 84:813\u2013822","journal-title":"Biochem Cell Biol"},{"key":"5611_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-6-32","volume":"6","author":"E Taherzadeh-Fard","year":"2011","unstructured":"Taherzadeh-Fard E, Saft C, Akkad DA et al (2011) PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. Mol Neurodegener 6:1\u20138","journal-title":"Mol Neurodegener"},{"key":"5611_CR39","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nsmb.2159","volume":"18","author":"HB Ngo","year":"2011","unstructured":"Ngo HB, Kaiser JT, Chan DC (2011) The mitochondrial transcription and packaging factor Tfam imposes a U-turn on mitochondrial DNA. Nat Struct Mol Biol 18:1290\u20131296. https:\/\/doi.org\/10.1038\/nsmb.2159","journal-title":"Nat Struct Mol Biol"},{"key":"5611_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/jmbi.1995.9889","volume":"249","author":"DJ Dairaghi","year":"1995","unstructured":"Dairaghi DJ, Shadel GS, Clayton DA (1995) Addition of a 29 residue carboxyl-terminal tail converts a simple HMG box-containing protein into a transcriptional activator. J Mol Biol 249:11\u201328","journal-title":"J Mol Biol"},{"key":"5611_CR41","first-page":"3496","volume":"8","author":"RP Fisher","year":"1988","unstructured":"Fisher RP, Clayton DA (1988) Purification and characterization of human mitochondrial transcription factor 1. Mol Cell Biol 8:3496\u20133509","journal-title":"Mol Cell Biol"},{"key":"5611_CR42","doi-asserted-by":"publisher","first-page":"11288","DOI":"10.1073\/pnas.1512131112","volume":"112","author":"C Kukat","year":"2015","unstructured":"Kukat C, Davies KM, Wurm CA et al (2015) Cross-strand binding of TFAM to a single mtDNA molecule forms the mitochondrial nucleoid. Proc Natl Acad Sci U S A 112:11288\u201311293","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5611_CR43","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/nar\/gkr787","volume":"40","author":"CS Malarkey","year":"2012","unstructured":"Malarkey CS, Bestwick M, Kuhlwilm JE et al (2012) Transcriptional activation by mitochondrial transcription factor A involves preferential distortion of promoter DNA. Nucleic Acids Res 40:614\u2013624","journal-title":"Nucleic Acids Res"},{"key":"5611_CR44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.sbi.2012.12.004","volume":"23","author":"A Rubio-Cosials","year":"2013","unstructured":"Rubio-Cosials A, Sol\u00e0 M (2013) U-turn DNA bending by human mitochondrial transcription factor A. Curr Opin Struct Biol 23:116\u2013124. https:\/\/doi.org\/10.1016\/j.sbi.2012.12.004","journal-title":"Curr Opin Struct Biol"},{"key":"5611_CR45","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.cell.2017.10.036","volume":"171","author":"HS Hillen","year":"2017","unstructured":"Hillen HS, Morozov YI, Sarfallah A et al (2017) Structural basis of mitochondrial transcription initiation. Cell 171:1072\u20131081","journal-title":"Cell"},{"key":"5611_CR46","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1093\/nar\/gkv235","volume":"43","author":"YI Morozov","year":"2015","unstructured":"Morozov YI, Parshin AV, Agaronyan K et al (2015) A model for transcription initiation in human mitochondria. Nucleic Acids Res 43:3726\u20133735","journal-title":"Nucleic Acids Res"},{"key":"5611_CR47","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/nar\/gkw1157","volume":"45","author":"A Ramachandran","year":"2017","unstructured":"Ramachandran A, Basu U, Sultana S et al (2017) Human mitochondrial transcription factors TFAM and TFB2M work synergistically in promoter melting during transcription initiation. Nucleic Acids Res 45:861\u2013874. https:\/\/doi.org\/10.1093\/nar\/gkw1157","journal-title":"Nucleic Acids Res"},{"key":"5611_CR48","doi-asserted-by":"publisher","first-page":"18410","DOI":"10.1073\/pnas.1008924107","volume":"107","author":"Y Matsushima","year":"2010","unstructured":"Matsushima Y, Goto Y, Kaguni LS (2010) Mitochondrial Lon protease regulates mitochondrial DNA copy number and transcription by selective degradation of mitochondrial transcription factor A (TFAM). Proc Natl Acad Sci U S A 107:18410\u201318415","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5611_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2004.09.037","volume":"119","author":"BM Spiegelman","year":"2004","unstructured":"Spiegelman BM, Heinrich R (2004) Biological control through regulated transcriptional coactivators. Cell 119:157\u2013167","journal-title":"Cell"},{"key":"5611_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.5.1868-1876.2000","author":"RB Vega","year":"2000","unstructured":"Vega RB, Huss JM, Kelly DP (2000) The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor \u03b1 in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol. https:\/\/doi.org\/10.1128\/MCB.20.5.1868-1876.2000","journal-title":"Mol Cell Biol"},{"key":"5611_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax8891","volume":"13","author":"A Jo","year":"2021","unstructured":"Jo A, Lee Y, Kam T-I et al (2021) Paris farnesylation prevents neurodegeneration in models of Parkinson\u2019s disease. Sci Transl Med 13:eaax8891. https:\/\/doi.org\/10.1126\/scitranslmed.aax8891","journal-title":"Sci Transl Med"},{"key":"5611_CR52","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","volume":"144","author":"J-H Shin","year":"2011","unstructured":"Shin J-H, Ko HS, Kang H et al (2011) PARIS (ZNF746) repression of PGC-1\u03b1 contributes to neurodegeneration in Parkinson\u2019s disease. Cell 144:689\u2013702","journal-title":"Cell"},{"key":"5611_CR53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ceb.2015.01.002","volume":"33","author":"A Eiyama","year":"2015","unstructured":"Eiyama A, Okamoto K (2015) PINK1\/Parkin-mediated mitophagy in mammalian cells. Curr Opin Cell Biol 33:95\u2013101. https:\/\/doi.org\/10.1016\/j.ceb.2015.01.002","journal-title":"Curr Opin Cell Biol"},{"key":"5611_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00367-7","volume":"15","author":"P Ge","year":"2020","unstructured":"Ge P, Dawson VL, Dawson TM (2020) PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease. Mol Neurodegener 15:20. https:\/\/doi.org\/10.1186\/s13024-020-00367-7","journal-title":"Mol Neurodegener"},{"key":"5611_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4060769","volume":"2020","author":"M Reutzel","year":"2020","unstructured":"Reutzel M, Grewal R, Dilberger B et al (2020) Cerebral mitochondrial function and cognitive performance during aging: a longitudinal study in NMRI mice. Oxid Med Cell Longev 2020:4060769","journal-title":"Oxid Med Cell Longev"},{"key":"5611_CR56","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.mito.2023.02.001","volume":"69","author":"PG Kulkarni","year":"2023","unstructured":"Kulkarni PG, Mohire VM, Bhaisa PK et al (2023) Mitofusin-2: functional switch between mitochondrial function and neurodegeneration. Mitochondrion 69:116\u2013129. https:\/\/doi.org\/10.1016\/j.mito.2023.02.001","journal-title":"Mitochondrion"},{"key":"5611_CR57","doi-asserted-by":"publisher","first-page":"12937","DOI":"10.1073\/pnas.1103295108","volume":"108","author":"FH Sterky","year":"2011","unstructured":"Sterky FH, Lee S, Wibom R et al (2011) Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc Natl Acad Sci U S A 108:12937\u201312942. https:\/\/doi.org\/10.1073\/pnas.1103295108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5611_CR58","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.freeradbiomed.2018.06.041","volume":"124","author":"G Chimienti","year":"2018","unstructured":"Chimienti G, Picca A, Sirago G et al (2018) Increased TFAM binding to mtDNA damage hot spots is associated with mtDNA loss in aged rat heart. Free Radic Biol Med 124:447\u2013453. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.06.041","journal-title":"Free Radic Biol Med"},{"key":"5611_CR59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mcn.2018.04.005","volume":"89","author":"SM Schindler","year":"2018","unstructured":"Schindler SM, Frank MG, Annis JL et al (2018) Pattern recognition receptors mediate pro-inflammatory effects of extracellular mitochondrial transcription factor A (TFAM). Mol Cell Neurosci 89:71\u201379. https:\/\/doi.org\/10.1016\/j.mcn.2018.04.005","journal-title":"Mol Cell Neurosci"},{"key":"5611_CR60","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neulet.2009.11.037","volume":"469","author":"K Gaweda-Walerych","year":"2010","unstructured":"Gaweda-Walerych K, Safranow K, Maruszak A et al (2010) Mitochondrial transcription factor A variants and the risk of Parkinson\u2019s disease. Neurosci Lett 469:24\u201329. https:\/\/doi.org\/10.1016\/j.neulet.2009.11.037","journal-title":"Neurosci Lett"},{"key":"5611_CR61","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neulet.2013.10.045","volume":"557","author":"AP Gatt","year":"2013","unstructured":"Gatt AP, Jones EL, Francis PT et al (2013) Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson\u2019s disease dementia but not dementia with Lewy bodies. Neurosci Lett 557:177\u2013180. https:\/\/doi.org\/10.1016\/j.neulet.2013.10.045","journal-title":"Neurosci Lett"},{"key":"5611_CR62","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neulet.2007.05.010","volume":"420","author":"AC Belin","year":"2007","unstructured":"Belin AC, Bj\u00f6rk BF, Westerlund M et al (2007) Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer\u2019s and Parkinson\u2019s disease. Neurosci Lett 420:257\u2013262","journal-title":"Neurosci Lett"},{"key":"5611_CR63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neulet.2004.07.070","volume":"369","author":"C G\u00fcnther","year":"2004","unstructured":"G\u00fcnther C, von Hadeln K, M\u00fcller-Thomsen T et al (2004) Possible association of mitochondrial transcription factor A (TFAM) genotype with sporadic Alzheimer disease. Neurosci Lett 369:219\u2013223","journal-title":"Neurosci Lett"},{"key":"5611_CR64","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3760\/cma.j.issn.0254-6450.2016.07.007","volume":"37","author":"H Jiang","year":"2016","unstructured":"Jiang H, Liu L, Sun DL et al (2016) Interaction between passive smoking and folic acid supplement during pregnancy on autism spectrum disorder behaviors in children aged 3 years. Zhonghua Liu Xing Bing Xue Za Zhi 37:940\u2013944. https:\/\/doi.org\/10.3760\/cma.j.issn.0254-6450.2016.07.007","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"5611_CR65","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neulet.2010.02.034","volume":"473","author":"AS Ebrahim","year":"2010","unstructured":"Ebrahim AS, Ko L, Yen S-H (2010) Reduced expression of peroxisome-proliferator activated receptor gamma coactivator-1\u03b1 enhances \u03b1-synuclein oligomerization and down regulates AKT\/GSK3\u03b2 signaling pathway in human neuronal cells that inducibly express \u03b1-synuclein. Neurosci Lett 473:120\u2013125","journal-title":"Neurosci Lett"},{"key":"5611_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ana.24294","volume":"77","author":"J Eschbach","year":"2015","unstructured":"Eschbach J, von Einem B, M\u00fcller K et al (2015) Mutual exacerbation of PGC-1\u03b1 deregulation and \u03b1-synuclein oligomerization. Ann Neurol 77:15","journal-title":"Ann Neurol"},{"key":"5611_CR67","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","volume":"68","author":"C Lippa","year":"2007","unstructured":"Lippa C, Duda J, Grossman M et al (2007) DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68:812\u2013819","journal-title":"Neurology"},{"key":"5611_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134087","volume":"10","author":"X Su","year":"2015","unstructured":"Su X, Chu Y, Kordower JH et al (2015) PGC- 1\u03b1 promoter methylation in Parkinson\u2019s disease. PLoS One 10:e0134087","journal-title":"PLoS One"},{"key":"5611_CR69","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.parkreldis.2018.02.037","volume":"51","author":"X-D Yang","year":"2018","unstructured":"Yang X-D, Qian Y-W, Xu S-Q et al (2018) Expression of the gene coading for PGC-1\u03b1 in peripheral blood leukocytes and related gene variants in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 51:30\u201335","journal-title":"Parkinsonism Relat Disord"},{"key":"5611_CR70","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.4161\/epi.25865","volume":"8","author":"E Masliah","year":"2013","unstructured":"Masliah E, Dumaop W, Galasko D, Desplats P (2013) Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics 8:1030\u20131038","journal-title":"Epigenetics"},{"key":"5611_CR71","doi-asserted-by":"publisher","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","volume":"298","author":"NB Ruderman","year":"2010","unstructured":"Ruderman NB, Julia Xu X, Nelson L et al (2010) AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 298:E751\u2013E760. https:\/\/doi.org\/10.1152\/ajpendo.00745.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"5611_CR72","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nature07813","volume":"458","author":"C Cant\u00f3","year":"2009","unstructured":"Cant\u00f3 C, Gerhart-Hines Z, Feige JN et al (2009) AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458:1056\u20131060","journal-title":"Nature"},{"key":"5611_CR73","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1113\/jphysiol.2010.194035","volume":"588","author":"VA Lira","year":"2010","unstructured":"Lira VA, Brown DL, Lira AK et al (2010) Nitric oxide and AMPK cooperatively regulate PGC-1\u03b1 in skeletal muscle cells. J Physiol 588:3551\u20133566. https:\/\/doi.org\/10.1113\/jphysiol.2010.194035","journal-title":"J Physiol"},{"key":"5611_CR74","doi-asserted-by":"publisher","first-page":"21590","DOI":"10.1074\/jbc.M109.070169","volume":"285","author":"K Aquilano","year":"2010","unstructured":"Aquilano K, Vigilanza P, Baldelli S et al (2010) Peroxisome proliferator-activated receptor \u03b3 co-activator 1\u03b1 (PGC-1\u03b1) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J Biol Chem 285:21590\u201321599","journal-title":"J Biol Chem"},{"key":"5611_CR75","doi-asserted-by":"publisher","unstructured":"Merry T, Ristow M (2016) Nuclear factor erythroid-derived 2-like 2 (NFE2L2, Nrf2) mediates exercise-induced mitochondrial biogenesis and antioxidant response in mice. The Journal of physiology 594:. https:\/\/doi.org\/10.1113\/JP271957","DOI":"10.1113\/JP271957"},{"key":"5611_CR76","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/iub.261","volume":"61","author":"T Wenz","year":"2009","unstructured":"Wenz T (2009) PGC-1\u03b1 activation as a therapeutic approach in mitochondrial disease. IUBMB Life 61:1051\u20131062. https:\/\/doi.org\/10.1002\/iub.261","journal-title":"IUBMB Life"},{"key":"5611_CR77","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","volume":"127","author":"M Lagouge","year":"2006","unstructured":"Lagouge M, Argmann C, Gerhart-Hines Z et al (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1\u03b1. Cell 127:1109\u20131122. https:\/\/doi.org\/10.1016\/j.cell.2006.11.013","journal-title":"Cell"},{"key":"5611_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-025-00831-5","volume":"11","author":"A Sirwi","year":"2025","unstructured":"Sirwi A, Rabie MA, Koshak AE et al (2025) 6-paradol mitigates rotenone-induced Parkinson\u2019s disease via shutting TNFR-1\/RIPK1\/RIPK3\/MLKL cascade and enhancement of PPAR\u03b3\/PGC-1\u03b1\/TFAM axis. Future J Pharm Sci 11:82. https:\/\/doi.org\/10.1186\/s43094-025-00831-5","journal-title":"Future J Pharm Sci"},{"key":"5611_CR79","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s11011-021-00748-x","volume":"36","author":"M-R Eteghadi","year":"2021","unstructured":"Eteghadi M-R, Nasehi M, Vaseghi S, Hesami-Tackallou S (2021) The effect of Crocin on TFAM and PGC-1\u03b1 expression and Catalase and Superoxide dismutase activities following cholestasis-induced neuroinflammation in the striatum of male Wistar rats. Metab Brain Dis 36:1791\u20131801. https:\/\/doi.org\/10.1007\/s11011-021-00748-x","journal-title":"Metab Brain Dis"},{"key":"5611_CR80","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cmet.2017.07.003","volume":"26","author":"M Jiang","year":"2017","unstructured":"Jiang M, Kauppila TES, Motori E et al (2017) Increased total mtDNA copy number cures male infertility despite unaltered mtDNA mutation load. Cell Metab 26:429\u2013436","journal-title":"Cell Metab"},{"key":"5611_CR81","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bbrc.2010.08.143","volume":"401","author":"S Nishiyama","year":"2010","unstructured":"Nishiyama S, Shitara H, Nakada K et al (2010) Over-expression of Tfam improves the mitochondrial disease phenotypes in a mouse model system. Biochem Biophys Res Commun 401:26\u201331","journal-title":"Biochem Biophys Res Commun"},{"key":"5611_CR82","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/hmg\/ddh109","volume":"13","author":"MI Ekstrand","year":"2004","unstructured":"Ekstrand MI, Falkenberg M, Rantanen A et al (2004) Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum Mol Genet 13:935\u2013944. https:\/\/doi.org\/10.1093\/hmg\/ddh109","journal-title":"Hum Mol Genet"},{"key":"5611_CR83","doi-asserted-by":"publisher","first-page":"8624","DOI":"10.1523\/JNEUROSCI.1957-08.2008","volume":"28","author":"Y Hayashi","year":"2008","unstructured":"Hayashi Y, Yoshida M, Yamato M et al (2008) Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor a in mice. J Neurosci 28:8624\u20138634","journal-title":"J Neurosci"},{"key":"5611_CR84","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1111\/j.1742-4658.2009.07094.x","volume":"276","author":"S Xu","year":"2009","unstructured":"Xu S, Zhong M, Zhang L et al (2009) Overexpression of Tfam protects mitochondria against \u03b2-amyloid-induced oxidative damage in SH-SY5Y cells. FEBS J 276:3800\u20133809","journal-title":"FEBS J"},{"key":"5611_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116755","volume":"175","author":"Y Li","year":"2024","unstructured":"Li Y, Lou N, Liu X et al (2024) Exploring new mechanisms of Imeglimin in diabetes treatment: amelioration of mitochondrial dysfunction. Biomed Pharmacother 175:116755. https:\/\/doi.org\/10.1016\/j.biopha.2024.116755","journal-title":"Biomed Pharmacother"},{"key":"5611_CR86","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature03354","volume":"434","author":"JT Rodgers","year":"2005","unstructured":"Rodgers JT, Lerin C, Haas W et al (2005) Nutrient control of glucose homeostasis through a complex of PGC-1\u03b1 and SIRT1. Nature 434:113\u2013118","journal-title":"Nature"},{"key":"5611_CR87","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11892-015-0671-9","volume":"15","author":"P Fernyhough","year":"2015","unstructured":"Fernyhough P (2015) Mitochondrial dysfunction in diabetic neuropathy: a series of unfortunate metabolic events. Curr Diab Rep 15:89","journal-title":"Curr Diab Rep"},{"key":"5611_CR88","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1111\/jdi.70092","volume":"16","author":"A Kato","year":"2025","unstructured":"Kato A, Nihei W, Yako H et al (2025) Imeglimin improves hyperglycemia and hypoglycemia-induced cell death and mitochondrial dysfunction in immortalized adult mouse Schwann IMS32 cells. J Diabetes Investig 16:1586\u20131596. https:\/\/doi.org\/10.1111\/jdi.70092","journal-title":"J Diabetes Investig"},{"key":"5611_CR89","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1111\/bph.12585","volume":"171","author":"S-M Aatsinki","year":"2014","unstructured":"Aatsinki S-M, Buler M, Salom\u00e4ki H et al (2014) Metformin induces PGC-1\u03b1 expression and selectively affects hepatic PGC-1\u03b1 functions. Br J Pharmacol 171:2351\u20132363. https:\/\/doi.org\/10.1111\/bph.12585","journal-title":"Br J Pharmacol"},{"key":"5611_CR90","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3390\/ijms24021459","volume":"24","author":"A Sierra-Magro","year":"2023","unstructured":"Sierra-Magro A, Bartolome F, Lozano-Mu\u00f1oz D et al (2023) C\/Ebp\u03b2 regulates TFAM expression, mitochondrial function and autophagy in cellular models of Parkinson\u2019s disease. Int J Mol Sci 24:1459","journal-title":"Int J Mol Sci"},{"key":"5611_CR91","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.mito.2014.04.008","volume":"17","author":"KZ Wang","year":"2014","unstructured":"Wang KZ, Zhu J, Dagda RK et al (2014) ERK-mediated phosphorylation of TFAM downregulates mitochondrial transcription: implications for Parkinson\u2019s disease. Mitochondrion 17:132\u2013140","journal-title":"Mitochondrion"},{"key":"5611_CR92","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mito.2023.09.002","volume":"73","author":"J Xue","year":"2023","unstructured":"Xue J, Zhang J, Zhang J et al (2023) The Parkinson\u2019s disease-associated mutation LRRK2 G2385R alters mitochondrial biogenesis via the PGC-1\u03b1-TFAM pathway. Mitochondrion 73:10\u201318","journal-title":"Mitochondrion"},{"key":"5611_CR93","doi-asserted-by":"publisher","first-page":"102095","DOI":"10.1016\/j.redox.2021.102095","volume":"46","author":"E Mart\u00edn-Monta\u00f1ez","year":"2021","unstructured":"Mart\u00edn-Monta\u00f1ez E, Valverde N, de Guevara-Miranda DL et al (2021) Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson\u2019s disease. Redox Biol 46:102095","journal-title":"Redox Biol"},{"key":"5611_CR94","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1096\/fj.10-173625","volume":"25","author":"CH Good","year":"2011","unstructured":"Good CH, Hoffman AF, Hoffer BJ et al (2011) Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson\u2019s disease. FASEB J 25:1333","journal-title":"FASEB J"},{"key":"5611_CR95","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.neuro.2017.06.002","volume":"64","author":"MR Langley","year":"2018","unstructured":"Langley MR, Ghaisas S, Ay M et al (2018) Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson\u2019s disease: relevance to gene and environment interactions in metal neurotoxicity. Neurotoxicology 64:240\u2013255","journal-title":"Neurotoxicology"},{"key":"5611_CR96","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.bbagen.2011.08.007","volume":"1820","author":"Y Piao","year":"2012","unstructured":"Piao Y, Kim HG, Oh MS, Pak YK (2012) Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP+-induced mitochondrial dysfunctions in neuronal cells. Biochimica et Biophysica Acta (BBA)-General Subjects 1820:577\u2013585","journal-title":"Biochimica et Biophysica Acta (BBA)-General Subjects"},{"key":"5611_CR97","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1111\/jcmm.14979","volume":"24","author":"M Baghi","year":"2020","unstructured":"Baghi M, Rostamian Delavar M, Yadegari E et al (2020) Modified level of miR-376a is associated with Parkinson\u2019s disease. J Cell Mol Med 24:2622\u20132634. https:\/\/doi.org\/10.1111\/jcmm.14979","journal-title":"J Cell Mol Med"},{"key":"5611_CR98","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41401-020-0487-2","volume":"42","author":"Q Cheng","year":"2021","unstructured":"Cheng Q, Chen J, Guo H et al (2021) Pyrroloquinoline quinone promotes mitochondrial biogenesis in rotenone-induced Parkinson\u2019s disease model via AMPK activation. Acta Pharmacol Sin 42:665\u2013678","journal-title":"Acta Pharmacol Sin"},{"key":"5611_CR99","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-024-01355-0","author":"X Li","year":"2024","unstructured":"Li X, Li Y, Wang K et al (2024) Isoquercitrin alleviates OGD\/R-induced oxidative stress and impaired mitochondrial biogenesis in SH-SY5Y cells via the NRF1\/TFAM pathway. Cell Biochem Biophys. https:\/\/doi.org\/10.1007\/s12013-024-01355-0","journal-title":"Cell Biochem Biophys"},{"key":"5611_CR100","first-page":"1","volume":"5","author":"S Meenalochani","year":"2015","unstructured":"Meenalochani S, Dheen ST, Tay SSW (2015) Molecular mechanism underlying PD pathogenesis-a possible role for sphingosine kinases and sphingosine-1-phosphate. J Alzheimers Dis Parkinsonism 5:1\u20136","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"5611_CR101","doi-asserted-by":"crossref","unstructured":"Siddiqui A, Chinta SJ, Mallajosyula JK et al (2012) Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for Parkinson\u2019s disease. Free Rad Biol Med 53:993\u20131003","DOI":"10.1016\/j.freeradbiomed.2012.05.024"},{"key":"5611_CR102","doi-asserted-by":"crossref","unstructured":"Xi Y, Feng D, Tao K et al (2018) MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2- dependent mitochondrial fusion via activation of PGC-1\u03b1. BBA-Mol Basis Dis 1864:2859\u20132870","DOI":"10.1016\/j.bbadis.2018.05.018"},{"key":"5611_CR103","doi-asserted-by":"crossref","unstructured":"Ma D, Liu X, Liu J et al (2019) Long-term liraglutide ameliorates nigrostriatal impairment viaregulating AMPK\/PGC-1a signaling in diabetic mice. Brain research 1714:126\u2013132","DOI":"10.1016\/j.brainres.2019.02.030"},{"key":"5611_CR104","doi-asserted-by":"publisher","unstructured":"Rezaee Z, Marandi SM, Alaei H, Esfarjani F (2020) Exercise-Induced Neuroprotection in the 6 Hydroxydopamine Parkinson\u2019s Disease Model. Neurotox Res 38:850\u2013858. https:\/\/doi.org\/10.1007\/s12640-020-00189-x","DOI":"10.1007\/s12640-020-00189-x"},{"key":"5611_CR105","doi-asserted-by":"crossref","unstructured":"Kim H, Lee J-Y, Park SJ et al (2022) S-nitrosylated PARIS Leads to the Sequestration of PGC-1\u03b1 into Insoluble Deposits in Parkinson\u2019s Disease Model. Cells 11:3682","DOI":"10.3390\/cells11223682"},{"key":"5611_CR106","doi-asserted-by":"crossref","unstructured":"Ye Q, Chen C, Si E et al (2017) Mitochondrial effects of PGC-1alpha silencing in MPP+ treated human SH-SY5Y neuroblastoma cells. Front Mol Neursci 10:164","DOI":"10.3389\/fnmol.2017.00164"},{"key":"5611_CR107","doi-asserted-by":"publisher","unstructured":"Rezaee Z, Marandi SM, Alaei H et al (2019) Effects of Preventive Treadmill Exercise on the Recovery of Metabolic and Mitochondrial Factors in the 6-Hydroxydopamine Rat Model of Parkinson\u2019s Disease. Neurotox Res 35:908\u2013917. https:\/\/doi.org\/10.1007\/s12640-019-0004-x","DOI":"10.1007\/s12640-019-0004-x"},{"key":"5611_CR108","doi-asserted-by":"crossref","unstructured":"Fan F, Li S, Wen Z et al (2020) Regulation of PGC-1\u03b1 mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson\u2019s disease. Aging (Albany NY) 12:9461","DOI":"10.18632\/aging.103219"},{"key":"5611_CR109","doi-asserted-by":"crossref","unstructured":"Chen H, Cao J, Zha L et al (2020) Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson\u2019s disease models through activating the MEF2-PGC1\u03b1 and BDNF\/CREB pathways. Aging (Albany NY) 12:14897","DOI":"10.18632\/aging.103551"},{"key":"5611_CR110","doi-asserted-by":"crossref","unstructured":"Eschbach J, von Einem B, M\u00fcller K et al (2015) Mutual exacerbation of PGC-1\u03b1 deregulation and \u03b1-synuclein oligomerization. Ann Neurol 77:15","DOI":"10.1002\/ana.24294"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05611-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05611-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05611-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T05:02:03Z","timestamp":1766811723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05611-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5611"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05611-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}